Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 477 Jan 1 – Oct 25, 2026
- Disclosed funding
- $20.2B 403 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| ST Secretome TherapeuticsCompany profile Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy | $30M | Series A | Biotech | United States | Investors | |
| PB Protuoso BiosciencesCompany profile Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases | $9.5M | Seed | Biotech | United States | Investors | |
| CH ClearNote HealthCompany profile Develops noninvasive blood-based early detection tests for pancreatic and ovarian cancers Develops noninvasive blood-based early detection tests for pancreatic and ovarian cancers | $52M | Series DSeries C+ | Biotech | United States | Investors | |
| PB Pacifico BiolabsCompany profile Produces mycelium-based meat alternatives using existing brewery fermentation infrastructure Produces mycelium-based meat alternatives using existing brewery fermentation infrastructure | €7M | Series A | Biotech, Foodtech | Germany | Investors | |
| b bitBiomeCompany profile Discovers and engineers novel enzymes and microbial strains for bio-based products using AI Discovers and engineers novel enzymes and microbial strains for bio-based products using AI | >$45M | Seed+Seed | Biotech | Japan | Investors | |
| PS P2 ScienceCompany profile Designs and manufactures renewable specialty ingredients for personal care, fragrance, and performance materials Designs and manufactures renewable specialty ingredients for personal care, fragrance, and performance materials | $23M | Undisclosed | Biotech, Climate tech | United States | Investors | |
| P PhytolonCompany profile Develops natural food colors using precision fermentation technology to replace synthetic dyes Develops natural food colors using precision fermentation technology to replace synthetic dyes | $23.6M | Series B | Biotech, Foodtech | Israel | Investors | |
| KD Kordata DynamicsCompany profile Provides AI-powered precision clinical trials platform using real-time neural biomarker data Provides AI-powered precision clinical trials platform using real-time neural biomarker data | Undisclosed | Pre-SeedPre-seed | Biotech, Healthtech | United States | Investors | |
| P PatinaCompany profile Discovers new scent molecules for fragrance and flavor industries using ML-based olfactory modeling Discovers new scent molecules for fragrance and flavor industries using ML-based olfactory modeling | $2M | Seed | Biotech | United States | Investors | |
| SC Synakis CorpCompany profile Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage | CA$2.6M | Pre-SeedPre-seed | Biotech | Canada | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
23rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.